Home › Type 2 Diabetes › Pennsylvania › Philadelphia
Pag-aaral pangklinika para sa Type 2 Diabetes sa Philadelphia, PA
Isang pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Philadelphia. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Nagre-recruitPhase 2
- Suburban Research Associates, West Chester · 24 mi ang layo
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Nagre-recruitPhase 3
- Thomas Jefferson University, Philadelphia
- Tristar Clinical Investigations PC, Philadelphia
- Suburban Research Associates, West Chester · 24 mi ang layo
Phenotyping Genetic Risk for Type 2 Diabetes
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Childrens Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Nagre-recruitPhase 3
- AURORA-2 Clinical Site, Philadelphia
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Nagre-recruitPhase 2
- Suburban Research Associates, West Chester · 24 mi ang layo
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Nagre-recruitPhase 2
- Suburban Research Associates, West Chester · 24 mi ang layo
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, Philadelphia
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Nagre-recruitPhase 3
- Children's Hosptl Philadelphia, Philadelphia
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Nagre-recruitPhase 3
- Children's Hospital of Philadelphia, Philadelphia
- St Christophers Hospital For Children, Philadelphia
The GRoceries Aimed at Increasing Nutrition Study
Nagre-recruitMay bayad para sa mga kalahok
- University of Pennsylvania, Philadelphia
CGM for Management of Type 2 Diabetes in Pregnancy
Nagre-recruit
- University of Pennsylvania, Philadelphia
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
Nagre-recruit
- Children's Hospital of Philadelphia, Philadelphia
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
Nagre-recruitObservasyonal na pag-aaral
- Children's Hospital of Philadelphia, Philadelphia
Transformative Research in Diabetic Nephropathy 2.0
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Penn Presbyterian Medical Center, Philadelphia
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
Nagre-recruit
- Thomas Jefferson University, Philadelphia
Pag-aaral para sa Type 2 Diabetes sa ibang lungsod
- San Antonio, TX37 pag-aaral
- Houston, TX31 pag-aaral
- Orlando, FL25 pag-aaral
- Boston, MA20 pag-aaral
- Chicago, IL19 pag-aaral
- Dallas, TX19 pag-aaral
- Miami, FL19 pag-aaral
- Columbus, OH18 pag-aaral
- Las Vegas, NV18 pag-aaral
- San Diego, CA17 pag-aaral
- Atlanta, GA17 pag-aaral
- Birmingham, AL16 pag-aaral
Iba pang pag-aaral sa Philadelphia
- Kanser (lahat ng uri)59 pag-aaral
- Kanser sa Suso56 pag-aaral
- Non-Small Cell Lung Cancer51 pag-aaral
- Metastatic Cancer46 pag-aaral
- Kanser sa Prostate44 pag-aaral
- Colorectal Cancer44 pag-aaral
- Kanser sa Ovary44 pag-aaral
- Kanser sa Baga36 pag-aaral
- Acute Myeloid Leukemia34 pag-aaral
- Pagkabigo ng Puso31 pag-aaral
- Kanser ng Endometrium28 pag-aaral
- Depression26 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.